Announcements
- Proposed REX Retail Offer
- Faron commences a share offering
- Initial positive data from Phase 2 of BEXMAB
- Issuance of warrants
- Founders named European Inventor Award finalists
- Replacement – Board Change
- Update on financial status
- Board Change
- Faron confirms plans under new leadership
- Appointment of Chief Financial Officer
More ▼
Key statistics
As of last trade Faron Pharmaceuticals Oy (4FR:FRA) traded at 1.17, 4.81% above its 52-week low of 1.12, set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.17 |
---|---|
High | 1.17 |
Low | 1.17 |
Bid | 1.20 |
Offer | 1.23 |
Previous close | 1.22 |
Average volume | 237.14 |
---|---|
Shares outstanding | 72.01m |
Free float | 13.05m |
P/E (TTM) | -- |
Market cap | 69.24m GBP |
EPS (TTM) | -0.2833 GBP |
Data delayed at least 15 minutes, as of Jun 10 2024 07:03 BST.
More ▼